2025年1月22日,强生公布了2024年第四季度及全年业绩,全年总营收888.21亿美元(合约6466亿人民币),同比增长4.3%。强生旗下两大核心业务板块——创新制药和医疗器械,分别实现了569.64亿美元以及318.57亿美元的收入。# 财报亮点2024财年公司实现销售额888.21亿美元,同比增长4.3%。GAAP净收入为14.1亿美元,同比增长5.6%,每股收益(EPS)达5.79美元,...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.